Results 121 to 130 of about 1,312 (139)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Hypotheses, 2021
Despite advances in the field, eating disorders (EDs) remain very challenging disorders to treat, especially when comorbid with posttraumatic stress disorder (PTSD). N-methyl-3,4-methylenedioxyamphetamine (MDMA)-assisted psychotherapy for treatment refractory PTSD shows great promise, with two-thirds of participants achieving full remission at 1 year ...
Timothy D, Brewerton +2 more
openaire +4 more sources
Despite advances in the field, eating disorders (EDs) remain very challenging disorders to treat, especially when comorbid with posttraumatic stress disorder (PTSD). N-methyl-3,4-methylenedioxyamphetamine (MDMA)-assisted psychotherapy for treatment refractory PTSD shows great promise, with two-thirds of participants achieving full remission at 1 year ...
Timothy D, Brewerton +2 more
openaire +4 more sources
Pharmacology Biochemistry and Behavior, 2005
MDMA (N-methyl-3,4-methylenedioxyamphetamine) produces a discriminative stimulus (DS) effect in animals, but attempts to completely block this action with selective neurotransmitter antagonists have not been very successful. Biochemically, MDMA can increase synaptic levels of serotonin, dopamine, and norepinephrine that, conceivably, might interact ...
Richard, Young +3 more
openaire +4 more sources
MDMA (N-methyl-3,4-methylenedioxyamphetamine) produces a discriminative stimulus (DS) effect in animals, but attempts to completely block this action with selective neurotransmitter antagonists have not been very successful. Biochemically, MDMA can increase synaptic levels of serotonin, dopamine, and norepinephrine that, conceivably, might interact ...
Richard, Young +3 more
openaire +4 more sources
Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues
European Journal of Pharmacology, 1991exaly

